Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: 6EH³RZ;   Drug: 6EHR³Z;   Drug: 6EHRZLfx Sponsors:   Institute of Tropical Medicine, Belgium;   Damien Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2019 Category: Research Source Type: clinical trials

Integrating Pediatric TB Services Into Child Healthcare Services in Africa
Conditions:   Tuberculosis;   Children, Only;   Diagnosis;   Delivery of Health Care Intervention:   Other: Integrated pediatric TB services Sponsors:   Elizabeth Glaser Pediatric AIDS Foundation;   UNITAID;   University of Sheffield;   Kenya Ministry of Health;   Cameroon Ministry of Public Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2019 Category: Research Source Type: clinical trials

Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: 6EH³RZ;   Drug: 6EHR³Z;   Drug: 6EHRZLfx Sponsors:   Institute of Tropical Medicine, Belgium;   Damien Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2019 Category: Research Source Type: clinical trials

Integrating Pediatric TB Services Into Child Healthcare Services in Africa
Conditions:   Tuberculosis;   Children, Only;   Diagnosis;   Delivery of Health Care Intervention:   Other: Integrated pediatric TB services Sponsors:   Elizabeth Glaser Pediatric AIDS Foundation;   UNITAID;   University of Sheffield;   Kenya Ministry of Health;   Cameroon Ministry of Public Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2019 Category: Research Source Type: clinical trials

Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: 6EH³RZ;   Drug: 6EHR³Z;   Drug: 6EHRZLfx Sponsors:   Institute of Tropical Medicine, Belgium;   Damien Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2019 Category: Research Source Type: clinical trials

Integrating Pediatric TB Services Into Child Healthcare Services in Africa
Conditions:   Tuberculosis;   Children, Only;   Diagnosis;   Delivery of Health Care Intervention:   Other: Integrated pediatric TB services Sponsors:   Elizabeth Glaser Pediatric AIDS Foundation;   UNITAID;   University of Sheffield;   Kenya Ministry of Health;   Cameroon Ministry of Public Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2019 Category: Research Source Type: clinical trials

Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: 6EH³RZ;   Drug: 6EHR³Z;   Drug: 6EHRZLfx Sponsors:   Institute of Tropical Medicine, Belgium;   Damien Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2019 Category: Research Source Type: clinical trials

Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis
Conditions:   HIV Infections;   Tuberculosis Interventions:   Other: Placebo;   Drug: Dolutegravir 50 mg Sponsors:   University of Cape Town;   Wellcome Trust;   Medecins Sans Frontieres, Netherlands Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2019 Category: Research Source Type: clinical trials

Nyaditum Resae ® as a Co-adjuvant During First-line Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut Microbiota
Condition:   Tuberculosis Interventions:   Dietary Supplement: Nyaditum resae®;   Other: Mannitol Sponsors:   University of Stellenbosch;   Fundació Institut Germans Trias i Pujol Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2019 Category: Research Source Type: clinical trials

Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis
Conditions:   HIV Infections;   Tuberculosis Interventions:   Other: Placebo;   Drug: Dolutegravir 50 mg Sponsors:   University of Cape Town;   Wellcome Trust;   Medecins Sans Frontieres, Netherlands Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2019 Category: Research Source Type: clinical trials

Nyaditum Resae ® as a Co-adjuvant During First-line Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut Microbiota
Condition:   Tuberculosis Interventions:   Dietary Supplement: Nyaditum resae®;   Other: Mannitol Sponsors:   University of Stellenbosch;   Fundació Institut Germans Trias i Pujol Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2019 Category: Research Source Type: clinical trials

Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis
Conditions:   HIV Infections;   Tuberculosis Interventions:   Other: Placebo;   Drug: Dolutegravir 50 mg Sponsors:   University of Cape Town;   Wellcome Trust;   Medecins Sans Frontieres, Netherlands Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2019 Category: Research Source Type: clinical trials

Nyaditum Resae ® as a Co-adjuvant During First-line Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut Microbiota
Condition:   Tuberculosis Interventions:   Dietary Supplement: Nyaditum resae®;   Other: Mannitol Sponsors:   University of Stellenbosch;   Fundació Institut Germans Trias i Pujol Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2019 Category: Research Source Type: clinical trials

Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis
Conditions:   HIV Infections;   Tuberculosis Interventions:   Other: Placebo;   Drug: Dolutegravir 50 mg Sponsors:   University of Cape Town;   Wellcome Trust;   Medecins Sans Frontieres, Netherlands Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2019 Category: Research Source Type: clinical trials

Nyaditum Resae ® as a Co-adjuvant During First-line Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut Microbiota
Condition:   Tuberculosis Interventions:   Dietary Supplement: Nyaditum resae®;   Other: Mannitol Sponsors:   University of Stellenbosch;   Fundació Institut Germans Trias i Pujol Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2019 Category: Research Source Type: clinical trials

Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis
Conditions:   HIV Infections;   Tuberculosis Interventions:   Other: Placebo;   Drug: Dolutegravir 50 mg Sponsors:   University of Cape Town;   Wellcome Trust;   Medecins Sans Frontieres, Netherlands Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2019 Category: Research Source Type: clinical trials

Nyaditum Resae ® as a Co-adjuvant During First-line Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut Microbiota
Condition:   Tuberculosis Interventions:   Dietary Supplement: Nyaditum resae®;   Other: Mannitol Sponsors:   University of Stellenbosch;   Fundació Institut Germans Trias i Pujol Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2019 Category: Research Source Type: clinical trials

Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis
Conditions:   HIV Infections;   Tuberculosis Interventions:   Other: Placebo;   Drug: Dolutegravir 50 mg Sponsors:   University of Cape Town;   Wellcome Trust;   Medecins Sans Frontieres, Netherlands Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2019 Category: Research Source Type: clinical trials

Nyaditum Resae ® as a Co-adjuvant During First-line Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut Microbiota
Condition:   Tuberculosis Interventions:   Dietary Supplement: Nyaditum resae®;   Other: Mannitol Sponsors:   University of Stellenbosch;   Fundació Institut Germans Trias i Pujol Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2019 Category: Research Source Type: clinical trials

Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis
Conditions:   HIV Infections;   Tuberculosis Interventions:   Other: Placebo;   Drug: Dolutegravir 50 mg Sponsors:   University of Cape Town;   Wellcome Trust;   Medecins Sans Frontieres, Netherlands Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2019 Category: Research Source Type: clinical trials

Nyaditum Resae ® as a Co-adjuvant During First-line Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut Microbiota
Condition:   Tuberculosis Interventions:   Dietary Supplement: Nyaditum resae®;   Other: Mannitol Sponsors:   University of Stellenbosch;   Fundació Institut Germans Trias i Pujol Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2019 Category: Research Source Type: clinical trials

Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis
Conditions:   HIV Infections;   Tuberculosis Interventions:   Other: Placebo;   Drug: Dolutegravir 50 mg Sponsors:   University of Cape Town;   Wellcome Trust;   Medecins Sans Frontieres, Netherlands Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2019 Category: Research Source Type: clinical trials

TB-Speed Pneumonia
Conditions:   Tuberculosis;   Severe Pneumonia Intervention:   Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

Community-based Tuberculosis Tracing and Preventive Therapy
Condition:   Tuberculosis Intervention:   Other: Screening and initiating preventive therapy in communities Sponsors:   Elizabeth Glaser Pediatric AIDS Foundation;   Epicentre;   University of Sheffield;   Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

TB-Speed Pneumonia
Conditions:   Tuberculosis;   Severe Pneumonia Intervention:   Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

Community-based Tuberculosis Tracing and Preventive Therapy
Condition:   Tuberculosis Intervention:   Other: Screening and initiating preventive therapy in communities Sponsors:   Elizabeth Glaser Pediatric AIDS Foundation;   Epicentre;   University of Sheffield;   Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

TB-Speed Pneumonia
Conditions:   Tuberculosis;   Severe Pneumonia Intervention:   Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

Community-based Tuberculosis Tracing and Preventive Therapy
Condition:   Tuberculosis Intervention:   Other: Screening and initiating preventive therapy in communities Sponsors:   Elizabeth Glaser Pediatric AIDS Foundation;   Epicentre;   University of Sheffield;   Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

TB-Speed Pneumonia
Conditions:   Tuberculosis;   Severe Pneumonia Intervention:   Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

Community-based Tuberculosis Tracing and Preventive Therapy
Condition:   Tuberculosis Intervention:   Other: Screening and initiating preventive therapy in communities Sponsors:   Elizabeth Glaser Pediatric AIDS Foundation;   Epicentre;   University of Sheffield;   Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

TB-Speed Pneumonia
Conditions:   Tuberculosis;   Severe Pneumonia Intervention:   Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

Community-based Tuberculosis Tracing and Preventive Therapy
Condition:   Tuberculosis Intervention:   Other: Screening and initiating preventive therapy in communities Sponsors:   Elizabeth Glaser Pediatric AIDS Foundation;   Epicentre;   University of Sheffield;   Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

TB-Speed Pneumonia
Conditions:   Tuberculosis;   Severe Pneumonia Intervention:   Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

Community-based Tuberculosis Tracing and Preventive Therapy
Condition:   Tuberculosis Intervention:   Other: Screening and initiating preventive therapy in communities Sponsors:   Elizabeth Glaser Pediatric AIDS Foundation;   Epicentre;   University of Sheffield;   Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

TB-Speed Pneumonia
Conditions:   Tuberculosis;   Severe Pneumonia Intervention:   Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

Community-based Tuberculosis Tracing and Preventive Therapy
Condition:   Tuberculosis Intervention:   Other: Screening and initiating preventive therapy in communities Sponsors:   Elizabeth Glaser Pediatric AIDS Foundation;   Epicentre;   University of Sheffield;   Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

TB-Speed Pneumonia
Conditions:   Tuberculosis;   Severe Pneumonia Intervention:   Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

Community-based Tuberculosis Tracing and Preventive Therapy
Condition:   Tuberculosis Intervention:   Other: Screening and initiating preventive therapy in communities Sponsors:   Elizabeth Glaser Pediatric AIDS Foundation;   Epicentre;   University of Sheffield;   Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

TB-Speed Pneumonia
Conditions:   Tuberculosis;   Severe Pneumonia Intervention:   Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials